| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.2M | — | -14.7% |
| Cost of Revenue | $12.9M | — | +9.9% |
| Gross Profit | $11.3M | — | -32.1% |
| R&D Expense | $4.4M | — | +8.4% |
| SG&A Expense | $6.7M | — | +3.1% |
| Operating Income | -$6.9M | — | -469.4% |
| Pre-tax Income | -$7.0M | — | -404.0% |
| Income Tax | $29K | — | -71.0% |
| Net Income | -$7.0M | — | -372.0% |
| EPS (Basic) | -$0.54 | — | -350.0% |
| EPS (Diluted) | -$0.54 | — | -350.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.2M | -9.8% | +22.2% |
| Accounts Receivable | $17.9M | -23.6% | -32.4% |
| Current Assets | $40.2M | -17.2% | -10.4% |
| Total Assets | $125.7M | -7.4% | -7.8% |
| Current Liabilities | $52.6M | -8.4% | -3.8% |
| Total Liabilities | $58.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $207K | — | +246.8% |
| Capital Expenditures | $1.7M | — | +91.1% |
| Investing Cash Flow | -$1.7M | — | -89.5% |
| Financing Cash Flow | $6K | — | +101.2% |
| Free Cash Flow | -$1.5M | — | -45.4% |
| -7.0% |
| Stockholders' Equity | $67.6M | -6.3% | -8.4% |